Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health
Rahela Aziz‐Bose, Daniel J. Zheng, Puja J. Umaretiya, Lenka Ilcisin, Kristen E. Stevenson, Victoria Koch, Ariana Valenzuela, Peter D. Cole, Lisa Gennarini, Justine M. Kahn, Kara M. Kelly, Thai Hoa Tran, Bruno Michon, Jennifer Welch, Lewis B. Silverman, Joanne Wolfe, Kira Bona
Abstract
Social determinants of health (SDoH) are associated with stark disparities in cancer outcomes, but systematic SDoH data collection is virtually absent from oncology clinical trials. Trial-based SDoH data are essential to ensure representation of marginalized populations, contextualize outcome disparities, and identify health-equity intervention opportunities. We report the feasibility of a pediatric oncology multicenter therapeutic trial-embedded SDoH investigation. Among 448 trial participants, 392 (87.5%) opted-in to the embedded SDoH study; 375 (95.7%) completed baseline surveys, with high longitudinal response rates (88.9-93.1%) over 24 months. Trial-embedded SDoH data collection is feasible and acceptable and must be consistently included within future oncology trials.